<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Met Based Drugs</journal-id><journal-id journal-id-type="iso-abbrev">Met Based Drugs</journal-id><journal-id journal-id-type="publisher-id">MBD</journal-id><journal-title-group><journal-title>Metal-Based Drugs</journal-title></journal-title-group><issn pub-type="ppub">0793-0291</issn><issn pub-type="epub">1687-5486</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18274603</article-id><article-id pub-id-type="pmc">PMC1894889</article-id><article-id pub-id-type="doi">10.1155/2007/15925</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>New Samarium(III), Gadolinium(III), and
Dysprosium(III) Complexes of Coumarin-3-Carboxylic
Acid as Antiproliferative Agents</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kostova</surname><given-names>Irena</given-names></name><xref ref-type="aff" rid="a1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Momekov</surname><given-names>Georgi</given-names></name><xref ref-type="aff" rid="a2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Stancheva</surname><given-names>Peya</given-names></name><xref ref-type="aff" rid="a3">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="a1"><sup>1</sup>Department of Chemistry, Faculty of Pharmacy, Medical University, 2 Dunav Street, 1000 Sofia, Bulgaria</aff><aff id="a2"><sup>2</sup>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Medical University, 2 Dunav Street, 1000 Sofia, Bulgaria</aff><aff id="a3"><sup>3</sup>Department of Inorganic Chemistry, University of Sofia, 1000 Sofia, Bulgaria</aff><author-notes><corresp id="cor1">*Irena Kostova: <email>irenakostova@yahoo.com</email></corresp><fn fn-type="other"><p>Recommended by Domenico Osella</p></fn></author-notes><pub-date pub-type="ppub"><year>2007</year></pub-date><pub-date pub-type="epub"><day>1</day><month>3</month><year>2007</year></pub-date><volume>2007</volume><elocation-id>15925</elocation-id><history><date date-type="received"><day>31</day><month>8</month><year>2006</year></date><date date-type="rev-recd"><day>16</day><month>11</month><year>2006</year></date><date date-type="accepted"><day>27</day><month>12</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Irena Kostova et al.</copyright-statement><copyright-year>2007</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>New complexes of samarium(III), gadolinium(III), and dysprosium(III) with coumarin-3-carboxylic acid (HCCA) were prepared by the reaction of the ligand with respective metal nitrates in ethanol. The structures of the final complexes were determined by means of physicochemical data, elemental analysis, IR and Raman spectra. The metal-ligand binding mode in the new Ln(III) complexes of coumarin-3-carboxylic acid was elucidated. The vibrational study gave evidence for bidentate coordination of 
CCA<sup>&#x02212;</sup> to Ln(III) ions through the carbonylic oxygen and the carboxylic oxygen atoms. The complexes were tested for antiproliferative activitiy on the chronic myeloid leukemia-derived K-562, overexpressing the BCR-ABL fusion protein. Cytotoxicity towards tumor cells was determined for a broad concentration range. The samarium salt exerted a very weak antiproliferative effect on these cells. This is in contrast to the lanthanide complexes, especially samarium complex, which exhibited potent antiproliferative activity. The present study confirms our previous observations that the lanthanide complexes of coumarins exhibit antiproliferative activity towards K-562 cell line.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. INTRODUCTION</title><p>Coumarin (1,2-benzopyrone) is structurally the least complex
member of a large class of compounds known as benzopyrones
[<xref rid="B1" ref-type="bibr">1</xref>]. The biological activities of coumarin and related
compounds are multiple and include antithrombotic activity
[<xref rid="B2" ref-type="bibr">2</xref>] and antimicrobial properties [<xref rid="B3" ref-type="bibr">3</xref>]. In addition, coumarins have been shown to inhibit <chem-struct>N</chem-struct>-methyl-<chem-struct>N</chem-struct>-nitrosourea, aflatoxin <chem-struct>B1</chem-struct> and
7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in
rats [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>]. More recently, coumarin derivatives have been
evaluated in the treatment of human immunodeficiency virus, due to
their ability to inhibit human immunodeficiency virus integrase
[<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>]. Since the late 1980s, a number of in vitro and in vivo studies have investigated the possible use of coumarins in the treatment of cancer [<xref rid="B8" ref-type="bibr">8</xref>]. The in vitro effects of coumarins on the growth of renal cell carcinoma that derived cell
lines showed that coumarin and 7-hydroxycoumarin were potent cytotoxic and cytostatic agents [<xref rid="B9" ref-type="bibr">9</xref>]. Several authors have
reported on the use of coumarin (1,2-benzopyrone), or its
metabolite 7-hydroxycoumarin, for the treatment of some human
carcinomas [<xref rid="B10" ref-type="bibr">10</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>]. There are several reports indicating that some coumarin compounds, including coumarin and 7-hydroxycoumarin, inhibit cell growth of cell lines of various
types of cancer [<xref rid="B14" ref-type="bibr">14</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>].</p><p>The coumarin derivatives have been the focus of our recent
research concerning the design of new cytotoxic agents. It is well
known that many investigations have proved that binding of a drug
to a metalloelement enhances its activity and, in some cases, the
complex possesses even more healing properties than the parent
drug. This has prompted us to investigate the metal binding
properties of several coumarin derivatives. We have recently
reported the synthesis of lanthanide(III) complexes with some
coumarins and the study of their anticancer activity
[<xref rid="B19" ref-type="bibr">19</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>]. In previous works [<xref rid="B19" ref-type="bibr">19</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>], we investigated the coordination behavior of some 4-hydroxycoumarins with cerium(III), lanthanum(III), and neodymium(III). In the course of these studies, considering that lanthanides(III) have an interesting but
not well-known biological role in living organisms as trace
elements, we have investigated the coordination properties of a
series of other lanthanides(III) with coumarin derivatives.</p><p>Thus, the aim of this work is to synthesize and characterize
complexes of samarium(III), gadolinium(III), and dysprosium(III)
with coumarin-3-carboxylic acid (see <xref ref-type="fig" rid="F1">Figure 1</xref>) and to
determine the antiproliferative effects of these complexes against
the chronic myeloid leukemia-derived K-562. The cell line is
characterized with a strong expression of <chem-struct>BCR</chem-struct>-<chem-struct>ABL</chem-struct> fusion protein (a constitutive nonreceptor tyrosine kinase) which
determines the low responsiveness of these cells to proapoptotic
stimuli [<xref rid="B30" ref-type="bibr">30</xref>].</p></sec><sec id="sec2"><title>2. METHODS</title><sec sec-type="subsection" id="subsec2.1"><title>2.1. Chemistry</title><p>The compounds used for preparing the solutions were Merck
products, p.a. grade: <chem-struct>Sm(NO<sub>3</sub>)<sub>3</sub> &#x000b7; 6H<sub>2</sub>O</chem-struct>, <chem-struct>Gd(NO<sub>3</sub>)<sub>3</sub> &#x000b7; 6H<sub>2</sub>O</chem-struct>, and <chem-struct>Dy(NO<sub>3</sub>)<sub>3</sub> &#x000b7; 5H<sub>2</sub>O</chem-struct>. Coumarin-3-carboxylic acid (<xref ref-type="fig" rid="F1">Figure 1</xref>) was used for the preparation of metal complexes as a ligand.</p><p>The complexes were synthesized by reaction of samarium(III),
gadolinium(III), and dysprosium(III) salts and the ligand, in
amounts equal to metal: ligand molar ratio of 1 : 2. The synthesis
of the complexes was made in different ratios (1 : 1, 1 : 2, 1 : 3)
but in all the cases the product was with the composition 1 : 2.
The complexes were prepared by adding ethanol solutions of
<chem-struct>Ln(III)</chem-struct> salts to ethanol solutions of the ligand. The
reaction mixture was stirred with an electromagnetic stirrer at
25&#x000b0;C for one hour. At the moment of mixing of the
solutions, precipitates were obtained. The precipitates were
filtered, washed several times with water and ethanol, and dried
in a desiccator to constant weight.</p><p>The complexes were insoluble in water, methanol, and ethanol and
well soluble in DMSO.</p><p>The carbon, hydrogen, and nitrogen contents of the compounds were
determined by elemental analysis. The water content was determined
by Metrohn Herizall E55 Karl Fisher Titrator and was confirmed by
TGA.</p><p>IR spectra (Nujol) were recorded on IR-spectrometer FTIR-8101M
Shimadzu. The Raman spectra of the ligand and their new
<chem-struct>Ln(III)</chem-struct> complexes were recorded with a Dilor
microspectrometer (Horiba-Jobin-Yvon, model LabRam) equipped with
a 1800 grooves/mm holographic grating. The 514.5 nm line
of an argon ion laser (Spectra Physics, model 2016) was used for
the probes excitation. The spectra were collected in a
backscattering geometry with a confocal Raman microscope equipped
with an Olympus LMPlanFL 50x objective and with a resolution of
2 cm<sup>&#x02212;1</sup>. The detection of Raman signal was carried out
with a Peltier-cooled CCD camera. The laser power of 100 mW was used in our measurements.</p></sec><sec sec-type="subsection" id="subsec2.2"><title>2.2. Pharmacology</title><p>The antiproliferative effects of the tested lanthanide complexes
and of the corresponding nitrate salts were assessed on the
chronic myeloid leukemia-derived K-562. The cells were maintained
as suspension-type cultures in a controlled environment: RPMI 1640
medium (Sigma), with 10% heat inactivated fetal bovine serum
(Sigma) and 2 mM <chem-struct>L</chem-struct>-glutamine (Sigma), in a &#x0201c;Heraeus&#x0201d; incubator with humidified atmosphere and 5% carbon dioxide, at 37&#x000b0;C. In order to keep the cells in log phase, cell
suspension was discarded 2 or 3 times per week and the cell
culture was refed with fresh RPMI-1640 aliquots.</p><p>The cell viability was determined using the MTT-dye reduction
assay. Briefly, exponentially growing cells were seeded in 96-well
microplates (100 <italic>&#x003bc;</italic>l/well) at a density of 1 &#x000d7; 10<sup>5</sup>
cells per ml and after 24-hour incubation at 37&#x000b0;C they were
exposed to various concentrations of the lanthanide complexes for
48 hours. For each concentration a set of 6 wells was treated.
After the incubation with the test compounds MTT solution
(10 mg/ml in PBS) was added (10 <italic>&#x003bc;</italic>l/well). The plates
were further incubated for 4 hours at 37&#x000b0;C and the formazan
crystals formed were dissolved through addition of
100 <italic>&#x003bc;</italic>l/well 5% solution of formic acid in 2-propanol
(Merck). The absorption of the samples was then measured using an
ELISA reader (Uniscan Titertec) at wavelength of 580 nm. The
blank solution consisted of 100 <italic>&#x003bc;</italic>l RPMI 1640 medium
(Sigma), 10 <italic>&#x003bc;</italic>l MTT stock, and 100 <italic>&#x003bc;</italic>l 5% formic
acid in 2-propanol. The survival fractions were calculated as
percentage of the untreated control using the formula
<disp-formula><label>(1)</label><mml:math id="M1"><mml:mrow><mml:mtext>SF</mml:mtext><mml:mtext>&#x02009;</mml:mtext><mml:mi>%</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mrow><mml:mtext>test</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mrow><mml:mtext>control</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math>,</disp-formula>
where <chem-struct>A<sub>test</sub></chem-struct> is the average value for the
absorption at a given concentration and <chem-struct>A<sub>control</sub></chem-struct> is the average absorption of the untreated control, respectively.</p><p>The stock solutions of the tested lanthanide complexes (at
20 mM) were freshly prepared in DMSO, and thereafter
consequently diluted in RPMI-1640 medium, in order to achieve the
desired final concentrations. At the final dilutions obtained, the
concentration of DMSO never exceeded 1%. The stock solutions
(20 mM, in water) of the nitrate salts of the lanthanides were
freshly prepared and following antibacterial filtration they were
accordingly diluted in RPMI-1640 medium.</p><p>Data processing, generation of dose-response curves, and IC<sub>50</sub>
calculations were performed using Microsoft Excel and Microcal
Origin software for PC.</p></sec></sec><sec id="sec3"><title>3. RESULTS AND DISCUSSION</title><sec sec-type="subsection" id="subsec3.1"><title>3.1. Chemistry</title><p>The new complexes were characterized by elemental analysis. The
metal ions were determined after mineralization. The water content
in the complexes was determined by Karl Fisher analysis. The
nature of the complexes was confirmed by IR and Raman
spectroscopy.</p><p>The data of the elemental analysis of the compounds obtained
serving as a basis for the determination of their empirical
formulas and the results of the Karl Fisher analysis are presented
in <xref ref-type="table" rid="T1">Table 1</xref>. There is good agreement between the
calculated and the found values.</p><p>The mode of bonding of the ligand to samarium(III),
gadolinium(III), and dysprosium(III) ions was elucidated by
recording the IR and Raman spectra of the complexes as compared
with those of the free ligand. The vibrational spectra of the
complexes showed new bands in comparison with these of the free
ligand which have been assigned to the rocking, waggling, and
metal-oxygen stretching vibrations.</p></sec><sec sec-type="subsection" id="subsec3.2"><title>3.2. Vibrational analysis</title><p>Depending on the orientation of the two donor groups,
C=O and <chem-struct>COO<sup>&#x02212;</sup></chem-struct>, different binding of the anion of coumarin-3-carboxylic acid <chem-struct>(CCA<sup>&#x02212;</sup>)</chem-struct> is possible. However, in most of the known lanathanide complexes, the metal-ligand interaction is mainly electrostatic by nature. To help further the
binding mode elucidation in the new <chem-struct>Sm(III)</chem-struct>,
<chem-struct>Gd(III)</chem-struct>, and <chem-struct>Dy(III)</chem-struct> complexes of <chem-struct>HCCA</chem-struct>,
detailed vibrational analysis was performed on the basis of
comparison of experimental vibrational spectra of HCCA and its
<chem-struct>Sm(III)</chem-struct>, <chem-struct>Gd(III)</chem-struct>, and <chem-struct>Dy(III)</chem-struct> complexes with
those theoretically predicted by us earlier [<xref rid="B31" ref-type="bibr">31</xref>] as
well as with literature data about related compounds. The data of
the experimental FT-IR and FT-Raman spectra of HCCA and its
<chem-struct>Sm(III)</chem-struct>, <chem-struct>Gd(III)</chem-struct>, and <chem-struct>Dy(III)</chem-struct> complexes are
given in <xref ref-type="table" rid="T2">Table 2</xref>. The FT-Raman spectra of the ligand and its <chem-struct>Ln(III)</chem-struct> complexes are presented in
<xref ref-type="fig" rid="F2">Figure 2</xref>.</p><p>The broadband at 3176 cm<sup>&#x02212;1</sup> in the <chem-struct>IR</chem-struct> spectrum of the ligand was assigned to the <italic>&#x003bd;</italic>
<chem-struct>(OH)</chem-struct> vibrational mode. This band was not detected in the spectra of the complexes, indicating that the deprotonated ligand form participates in the complexes. The bands in the 3060&#x02013;2920 cm<sup>&#x02212;1</sup> region were assigned to <italic>&#x003bd;</italic>
<chem-struct>(CH)</chem-struct> modes of <chem-struct>HCCA</chem-struct>. In the <chem-struct>IR</chem-struct> spectra of <chem-struct>Sm(III), Gd(III), and Dy(III)</chem-struct> complexes they remain almost unchanged.</p><p>The strong <chem-struct>IR</chem-struct> bands at 1746 cm<sup>&#x02212;1</sup> and 1685 cm<sup>&#x02212;1</sup> and the medium Raman bands at 1729, 1676, and
1663 cm<sup>&#x02212;1</sup> were assigned to <italic>&#x003bd;</italic>(C=O) modes of
the carboxylic and carbonylic groups, respectively. The high IR
intensity of these bands retained in the spectra of <chem-struct>Sm(III)</chem-struct>, <chem-struct>Gd(III)</chem-struct>, and <chem-struct>Dy(III)</chem-struct> complexes, the <italic>&#x003bd;</italic>
<chem-struct>(C=O)<sub>carboxylic</sub></chem-struct> band was shifted to lower frequency (1703 cm<sup>&#x02212;1</sup>, 1703 cm<sup>&#x02212;1</sup>, 1705 cm<sup>&#x02212;1</sup> for <chem-struct>Sm(III), Gd(III), and Dy(III)</chem-struct> complexes, resp.), and the <italic>&#x003bd;</italic>
<chem-struct>(C=O)<sub>carbonylic</sub></chem-struct> band showed also a position change (1672 cm<sup>&#x02212;1</sup>, 1672 cm<sup>&#x02212;1</sup>, 1674 cm<sup>&#x02212;1</sup> for <chem-struct>Sm(III), Gd(III), and Dy(III)</chem-struct> complexes, resp.). The same shift effects were observed in the
Raman spectra of the complexes.</p><p>In agreement with the literature data [<xref rid="B31" ref-type="bibr">31</xref>], the bands
observed in the 1650&#x02013;1330 cm<sup>&#x02212;1</sup> frequency range are due
to the <italic>&#x003bd;</italic>
<chem-struct>(CC)</chem-struct> stretching vibrations of HCCA coumarin ring. The bands that are typical for the coumarin vibrations were
not shifted significantly in the spectra of <chem-struct>Sm(III), Gd(III), and Dy(III)</chem-struct> complexes, which indicated that the <chem-struct>Ln(III)</chem-struct> cations did not produce substantial polarization on the coumarin ring. The strong <chem-struct>IR</chem-struct> (at 1613 and 1569 cm<sup>&#x02212;1</sup>) and Raman (at 1608 and 1559 cm<sup>&#x02212;1</sup>) bands are attributed to the <italic>&#x003bd;</italic>
<chem-struct>(C=C)</chem-struct> stretching vibrations of HCCA coumarin fragment. Their positions and intensities are almost retained and the second band is split in
the complexes. The bands at 1489, 1453, and 1374 cm<sup>&#x02212;1</sup>
<chem-struct> (IR)</chem-struct> and at 1483, 1442, and 1363 cm<sup>&#x02212;1</sup> (Raman), which also are assigned to the <italic>&#x003bd;</italic>
<chem-struct>(CC)</chem-struct> modes of <chem-struct>HCCA</chem-struct>, show shifts in the <chem-struct>IR</chem-struct> and Raman spectra of <chem-struct>Sm(III), Gd(III), and Dy(III)</chem-struct> complexes and at the same time the intensity of these bands increases. The induced polarization by Ln(III)&#x02212;CCA interaction produces electron
density distribution in the conjugated coumarin ring and as a result the <italic>&#x003bd;</italic>
<chem-struct>(CC)</chem-struct> frequencies change their positions and intensity.</p><p>The strong bands at 1228 cm<sup>&#x02212;1</sup> (<chem-struct>IR</chem-struct> spectrum of HCCA) and at 1216 cm<sup>&#x02212;1</sup> (Raman spectrum of HCCA) and the medium one at 989 cm<sup>&#x02212;1</sup>, in the <chem-struct>IR</chem-struct> spectrum of HCCA, were assigned to the lactone <italic>&#x003bd;</italic>
<chem-struct>(C&#x02212;O)</chem-struct> modes, respectively. In the complexes, these modes were shifted to lower frequency. In agreement with <chem-struct>Ln(III)&#x02212;O<sub>carbonyl</sub></chem-struct> interaction, the induced polarization on <chem-struct>CCA<sup>&#x02212;</sup></chem-struct> leads to changes of the C&#x02212;O lactone bond lengths as well as of their frequencies in a direction mentioned above.</p><p>The following bands, observed in the <chem-struct>IR</chem-struct> spectra of the
complexes, are assigned to the vibrational modes of the <chem-struct>NO<sub>3</sub></chem-struct> group: 1263 cm<sup>&#x02212;1</sup> (<chem-struct>Sm</chem-struct> complex), 1262 cm<sup>&#x02212;1</sup> (<chem-struct>Gd</chem-struct> complex), 1262 cm<sup>&#x02212;1</sup> (<chem-struct>Dy</chem-struct> complex) for <italic>&#x003bd;</italic>
<chem-struct>(NO)<sub>bonded</sub></chem-struct>; 1053 cm<sup>&#x02212;1</sup> (<chem-struct>Sm</chem-struct> complex), 1049 cm<sup>&#x02212;1</sup> (<chem-struct>Gd</chem-struct> complex), 1049 cm<sup>&#x02212;1</sup> (<chem-struct>Dy</chem-struct> complex) for <italic>&#x003b4;</italic>
<chem-struct>(ONO)</chem-struct>; 786 cm<sup>&#x02212;1</sup> (<chem-struct>Sm</chem-struct> complex), 791 cm<sup>&#x02212;1</sup> (<chem-struct>Gd</chem-struct> complex), 781 cm<sup>&#x02212;1</sup> (<chem-struct>Dy</chem-struct> complex) for <italic>&#x003b4;</italic>
<chem-struct>(ONO)</chem-struct>; and 725 cm<sup>&#x02212;1</sup> (<chem-struct>Sm</chem-struct> complex), 725 cm<sup>&#x02212;1</sup> (<chem-struct>Gd</chem-struct> complex), 713 cm<sup>&#x02212;1</sup> (<chem-struct>Dy</chem-struct> complex) for <italic>&#x003b4;</italic>
<chem-struct>(ONO)</chem-struct>. Some of them also appear in the Raman spectra of the complexes: 1040 cm<sup>&#x02212;1</sup> (<chem-struct>Sm</chem-struct> complex), 1040 cm<sup>&#x02212;1</sup> (<chem-struct>Gd</chem-struct> complex), 1043 cm<sup>&#x02212;1</sup> (<chem-struct>Dy</chem-struct> complex) for <italic>&#x003b4;</italic>
<chem-struct>(ONO)</chem-struct>; 777 cm<sup>&#x02212;1</sup> (<chem-struct>Sm</chem-struct> complex), 772 cm<sup>&#x02212;1</sup> (<chem-struct>Gd</chem-struct> complex), 777 cm<sup>&#x02212;1</sup> (<chem-struct>Dy</chem-struct> complex) for <italic>&#x003b4;</italic>
<chem-struct>(ONO)</chem-struct>. Because of the predominant electrostatic character of the Ln&#x02212;O bonding, the bands corresponding to the <italic>&#x003bd;</italic>
<chem-struct>(Ln&#x02212;O)</chem-struct> modes have low intensities, they are coupled with other modes and hence, their assignment is unreliable. The doublet bands observed in the <chem-struct>IR</chem-struct> spectra of the complexes at 767, 748 cm<sup>&#x02212;1</sup> (<chem-struct>Sm</chem-struct> complex), 768, 749 cm<sup>&#x02212;1</sup> (<chem-struct>Gd</chem-struct> complex), 766, 750 cm<sup>&#x02212;1</sup> (<chem-struct>Dy</chem-struct> complex), the bands at 459 cm<sup>&#x02212;1</sup> (<chem-struct>Sm</chem-struct> complex), 457 cm<sup>&#x02212;1</sup> (<chem-struct>Gd</chem-struct> complex), 457 cm<sup>&#x02212;1</sup> (<chem-struct>Dy</chem-struct> complex), and the bands at 449 cm<sup>&#x02212;1</sup> for <chem-struct>Sm(III), Gd(III), and Dy(III)</chem-struct> complexes were assigned to <italic>&#x003bd;</italic>
<chem-struct>(Ln&#x02212;O)<sub>carboxylic</sub></chem-struct> and <italic>&#x003bd;</italic>
<chem-struct>(Ln&#x02212;O)<sub>carbonylic</sub></chem-struct> modes, respectively.</p><p>On the basis of the above-detailed vibrational study we can
conclude that the metal-ligand bonding in <chem-struct>Ln(III)</chem-struct> complexes
of coumarin-3-carboxylic acid appeared to be strongly ionic with
very small donor-acceptor character. The vibrational study gave
evidence for bidentate coordination of <chem-struct>CCA<sup>&#x02212;</sup></chem-struct> to <chem-struct>Sm(III), Gd(III), and Dy(III)</chem-struct> ions through the carbonylic oxygen and the carboxylic oxygen.</p><p>A survey of the <chem-struct><sup>1</sup>H</chem-struct> NMR spectral data reveals downfield chemical shifts of the protons in the <chem-struct>Ln(III)</chem-struct> complexes spectra relative to the free ligand. The resonances due to protons
of the ligand are considerably broadened and shifted indicating
complexation. The ligand shows a peak at 13.2 ppm due to the
carboxylic proton [<xref rid="B31" ref-type="bibr">31</xref>]. This peak is absent in the spectra of
the complexes due to the deprotonation of the carboxylic group. In
the <chem-struct><sup>13</sup>C</chem-struct> NMR spectra of the complexes, the largest upfield chemical shifts are observed for the carbon atoms which
are neighbors of the carboxylic and carbonylic oxygens and this
finding confirms their participation in Ln(III)&#x02212;CCA interaction.</p><p>The solvent <chem-struct>DMSO</chem-struct> was used for the <chem-struct>NMR</chem-struct> measurements because the solubility of the complexes in noncoordinating
solvents was too low. <chem-struct>DMSO</chem-struct> is well known as a very reactive
agent. <chem-struct>DMSO</chem-struct> molecule could indeed bind to the metal and
give rise to equilibrium, fast on the <chem-struct>NMR</chem-struct> time scale,
involving the <chem-struct>DMSO</chem-struct> molecule as an additional ligand,
because of the high coordination number of <chem-struct>Ln(III)</chem-struct>. Taking
into consideration the obtained data, we can say the following.
The results of <chem-struct>NMR</chem-struct> spectra, discussed above, and the
results of the pharmacological activity, presented below, all made
in <chem-struct>DMSO</chem-struct>, give us reason to suggest that in these conditions
(in the solution of <chem-struct>DMSO</chem-struct>) the complexes are present. The
stability of the complexes is of great interest with respect to
their further pharmacological properties (not cytotoxicity test)
and will be the subject of coming investigations which are in
progress.</p><p>Our previous molecular electrostatic potential (MEP) study on the
preferred reactive sites of <chem-struct>CCA<sup>&#x02212;</sup></chem-struct> in the gas phase and in solution revealed two regions suitable for electrophilic attack
and binding: between the deprotonated carboxylic and the
carbonylic oxygens and between the carboxylic oxygens
[<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>]. To suggest the binding mode of HCCA, a detail theoretical and vibrational investigation based on Raman, FTIR, and DFT/B3LYP/SVP studies of HCCA, its deprotonated form
<chem-struct>(CCA<sup>&#x02212;</sup>)</chem-struct>, <chem-struct>KCCA</chem-struct>, and <chem-struct>Ln(CCA)<sub>2</sub>(NO<sub>3</sub>)(H<sub>2</sub>O)</chem-struct> species, was performed. Two bidentate binding modes of <chem-struct>CCA<sup>&#x02212;</sup></chem-struct> to <chem-struct>Ln(III)</chem-struct> were modeled: (1) through the deprotonated carboxylic and the carbonylic oxygens and (2) through both carboxylic oxygens. The vibrational analysis and the electronic energy calculations pointed to the first binding as more probable. On the basis of
detailed DFT study of the vibrational behavior of <chem-struct>HCCA</chem-struct>, <chem-struct>CCA<sup>&#x02212;</sup></chem-struct>, <chem-struct>KCCA</chem-struct>, and <chem-struct>Ln(CCA)<sub>2</sub>(NO<sub>3</sub>)(H<sub>2</sub>O)</chem-struct> species and comparison of the theoretical and experimental vibrational spectra, it was established that <chem-struct>CCA<sup>&#x02212;</sup></chem-struct> is bidentate bound to <chem-struct>Ln(III)</chem-struct> through the carboxylic and the carbonylic atoms. As seen from the vibrational spectra, the <chem-struct>NO<sub>3</sub></chem-struct> group is bidentate coordinated, the calculated and experimental <chem-struct>NO<sub>3</sub></chem-struct> modes for the complexes were found at very similar wavenumbers, and the assignment of the
<chem-struct>NO<sub>3</sub></chem-struct> vibrational modes is in good agreement with literature data [<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>].</p><p>Moreover, the metal-ligand binding mode of coumarin-3-carboxylic
acid <chem-struct>(HCCA)</chem-struct> was recently explained by us through modeling
of the Ln(III)-coumarin-3-carboxylic acid structures, where
<chem-struct>Ln = La, Ce, Nd</chem-struct> [<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>]. It was suggested that
coumarin-3-carboxylic acid binds to the <chem-struct>Ln(III)</chem-struct> ions
through both oxygen atoms of the carboxylic and carbonylic groups
from the ligands and through the oxygen atoms of
<chem-struct>NO<sub>3</sub><sup>&#x02212;</sup></chem-struct>, and thus, the central ion <chem-struct>Ln(III)</chem-struct> is six-coordinated. The <chem-struct>NBO</chem-struct> analysis of the complexes suggests predominantly ionic character of the Ln&#x02212;CCA bond with slight ligand-metal charge transfer [<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>].</p><p>Nevertheless, we have to take into consideration that the
coordination number 6 for these central metal ions indeed is too
low, but not impossible for lanthanide<chem-struct>(III)</chem-struct> ions
[<xref rid="B19" ref-type="bibr">19</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>]. One plausible mode of coordination might involve also the water molecules, which is
typical for coordination compounds of lanthanides.</p><p>On the bases of our experimental spectral data and our theoretical
density function calculations [<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>], we were able to suggest the most probable structure of these <chem-struct>Ln(III)</chem-struct> complexes.</p></sec><sec sec-type="subsection" id="subsec3.3"><title>3.3. Pharmacology</title><p>The preliminary pharmacological screening performed revealed that
all of the lanthanide complexes exerted antiproliferative effects
against the chronic myeloid leukemia-derived K-562 line in a
concentration-dependent matter, which enabled the construction of
concentration response curves as depicted on Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F5">5</xref>, <xref ref-type="fig" rid="F6">6</xref>, <xref ref-type="fig" rid="F7">7</xref>, <xref ref-type="fig" rid="F8">8</xref> and <xref ref-type="table" rid="T3">Table 3</xref>. In contrast to the <chem-struct>Sm(III)</chem-struct> and <chem-struct>Gd(III)</chem-struct> complexes with coumarin-3-carboxylic acid, <chem-struct>Dy(CCA)<sub>2</sub>(NO<sub>3</sub>) &#x000b7; H<sub>2</sub>O</chem-struct> failed to induce 50%
inhibition of the cellular proliferation within the concentration range under investigation.</p><p>Interestingly, the <chem-struct>Gd(III)</chem-struct> and 
<chem-struct>Dy(III)</chem-struct> nitrates were
found to exert considerable antiprolferative effects (Figures
<xref ref-type="fig" rid="F6">6</xref>, <xref ref-type="fig" rid="F7">7</xref>, <xref ref-type="fig" rid="F8">8</xref>), superior to
those of the complexes thereof. In contrast, despite the
considerable activity of the samarium complex, the corresponding
nitrate salt <chem-struct>Sm(NO<sub>3</sub>)<sub>3</sub> &#x000b7; 6H<sub>2</sub>O</chem-struct> (<xref ref-type="fig" rid="F6">Figure 6</xref>) caused only marginal inhibitory effects against K-562 (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p></sec></sec><sec id="sec4"><title>4. CONCLUSION</title><p>The results from this study demonstrate the antiprolferative
potential of three novel lanthanide coordination compounds of
coumarin-3-carboxylic acid derivatives, in line with our preceding
papers concerning the activity of lanthanide 
(<chem-struct>Ce(III), La(III), and Nd(III)</chem-struct>) coordination compounds with diverse coumarin ligands [<xref rid="B19" ref-type="bibr">19</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>]. In our hands, the samarium<chem-struct>(III)</chem-struct> complex of coumarin-3-carboxylic acid proved to be the most active antiproliferative agent among the novel complexes and thus it necessitates further more detailed pharmacological evaluation. The complex formation proved to be
detrimental for the efficacy of <chem-struct>Gd(III)</chem-struct> and <chem-struct>Dy(III)</chem-struct> compounds as in both cases the nitrates exerted superior efficacy
versus the corresponding coordination compounds.</p></sec></body><back><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>D</given-names></name><name><surname>O'Kennedy</surname><given-names>R</given-names></name><name><surname>Moran</surname><given-names>E</given-names></name><name><surname>Cox</surname><given-names>D</given-names></name><name><surname>Prosser</surname><given-names>E</given-names></name><name><surname>Thornes</surname><given-names>RD</given-names></name></person-group><article-title>The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds</article-title><source><italic>Drug Metabolism Reviews</italic></source><year>1990</year><volume>22</volume><issue>5</issue><fpage>503</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">2078993</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoult</surname><given-names>JRS</given-names></name><name><surname>Pay&#x000e1;</surname><given-names>M</given-names></name></person-group><article-title>Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential</article-title><source><italic>General Pharmacology</italic></source><year>1996</year><volume>27</volume><issue>4</issue><fpage>713</fpage><lpage>722</lpage><pub-id pub-id-type="pmid">8853310</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurin</surname><given-names>P</given-names></name><name><surname>Ferroud</surname><given-names>D</given-names></name><name><surname>Klich</surname><given-names>M</given-names></name><etal/></person-group><article-title>Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B</article-title><source><italic>Bioorganic and Medicinal Chemistry Letters</italic></source><year>1999</year><volume>9</volume><issue>14</issue><fpage>2079</fpage><lpage>2084</lpage><pub-id pub-id-type="pmid">10450985</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>A</given-names></name><name><surname>Hanawalt</surname><given-names>PC</given-names></name></person-group><article-title>Histone H3 and heat shock protein GRP78 are selectively cross-linked to DNA by photoactivated gilvocarcin V in human fibroblasts</article-title><source><italic>Cancer Research</italic></source><year>2000</year><volume>60</volume><issue>14</issue><fpage>3921</fpage><lpage>3926</lpage><pub-id pub-id-type="pmid">10919670</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>VP</given-names></name><name><surname>Ellis</surname><given-names>EM</given-names></name><name><surname>Manson</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Chemoprevention of aflatoxin B<sub>1</sub> hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B<sub>1</sub>-aldehyde reductase, the glutathione <italic>S</italic>-transferase A5 and P1 subunits, and NAD(P)H: quinone oxidoreductase in rat liver</article-title><source><italic>Cancer Research</italic></source><year>2000</year><volume>60</volume><issue>4</issue><fpage>957</fpage><lpage>969</lpage><pub-id pub-id-type="pmid">10706111</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkiacharian</surname><given-names>S</given-names></name><name><surname>Thuy</surname><given-names>DT</given-names></name><name><surname>Sicsic</surname><given-names>S</given-names></name><name><surname>Bakhchinian</surname><given-names>R</given-names></name><name><surname>Kurkjian</surname><given-names>R</given-names></name><name><surname>Tonnaire</surname><given-names>T</given-names></name></person-group><article-title>Structure-activity relationships of some 3-substituted-4-hydroxycoumarins as HIV-1 protease inhibitors</article-title><source><italic>Il Farmaco</italic></source><year>2002</year><volume>57</volume><issue>9</issue><fpage>703</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">12385519</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Morris-Natschke</surname><given-names>SL</given-names></name><name><surname>Lee</surname><given-names>K-H</given-names></name></person-group><article-title>Recent progress in the development of coumarin derivatives as potent anti-HIV agents</article-title><source><italic>Medicinal Research Reviews</italic></source><year>2003</year><volume>23</volume><issue>3</issue><fpage>322</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">12647313</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>EM</given-names></name><name><surname>Ryles</surname><given-names>M</given-names></name><name><surname>Butler</surname><given-names>K</given-names></name><name><surname>Weiss</surname><given-names>L</given-names></name></person-group><article-title>Treatment of advanced renal cell carcinoma (RCC) with coumarin and cimetidine: longterm follow-up of patients treated on a phase I trial</article-title><source><italic>Journal of Cancer Research and Clinical Oncology</italic></source><year>1994</year><volume>120</volume><fpage>535</fpage><lpage>538</lpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conley</surname><given-names>D</given-names></name><name><surname>Marshall</surname><given-names>EM</given-names></name></person-group><article-title>Effects of coumarin on human tumour cell growth and cell cycle analysis in vitro</article-title><source><italic>Proceedings of the American Association for Cancer Research</italic></source><year>1987</year><volume>28</volume><fpage>63</fpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornes</surname><given-names>RD</given-names></name><name><surname>Daly</surname><given-names>L</given-names></name><name><surname>Lynch</surname><given-names>G</given-names></name><etal/></person-group><article-title>Treatment with coumarin to prevent or delay recurrence of malignant melanoma</article-title><source><italic>Journal of Cancer Research and Clinical Oncology</italic></source><year>1994</year><volume>120, supplement 1</volume><fpage>S32</fpage><lpage>S34</lpage><pub-id pub-id-type="pmid">8132701</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>ME</given-names></name><name><surname>Mohler</surname><given-names>JL</given-names></name><name><surname>Edmonds</surname><given-names>K</given-names></name><etal/></person-group><article-title>An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin</article-title><source><italic>Journal of Cancer Research and Clinical Oncology</italic></source><year>1994</year><volume>120, supplement 1</volume><fpage>S39</fpage><lpage>S42</lpage><pub-id pub-id-type="pmid">8132703</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohler</surname><given-names>JL</given-names></name><name><surname>Williams</surname><given-names>BT</given-names></name><name><surname>Thompson</surname><given-names>IM</given-names></name><name><surname>Marshall</surname><given-names>ME</given-names></name></person-group><article-title>Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma</article-title><source><italic>Journal of Cancer Research and Clinical Oncology</italic></source><year>1994</year><volume>120, supplement 1</volume><fpage>S35</fpage><lpage>S38</lpage><pub-id pub-id-type="pmid">8132702</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Angerer</surname><given-names>E</given-names></name><name><surname>Kager</surname><given-names>M</given-names></name><name><surname>Maucher</surname><given-names>A</given-names></name></person-group><article-title>Antitumour activity of coumarin in prostate and mammary cancer models</article-title><source><italic>Journal of Cancer Research and Clinical Oncology</italic></source><year>1994</year><volume>120, supplement 1</volume><fpage>S14</fpage><lpage>S16</lpage><pub-id pub-id-type="pmid">8132695</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lake</surname><given-names>BG</given-names></name></person-group><article-title>Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment</article-title><source><italic>Food and Chemical Toxicology</italic></source><year>1999</year><volume>37</volume><issue>4</issue><fpage>423</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">10418958</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>ME</given-names></name><name><surname>Butler</surname><given-names>K</given-names></name><name><surname>Fried</surname><given-names>A</given-names></name></person-group><article-title>Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies</article-title><source><italic>Molecular Biotherapy</italic></source><year>1991</year><volume>3</volume><issue>3</issue><fpage>170</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">1768368</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>ME</given-names></name><name><surname>Kervin</surname><given-names>K</given-names></name><name><surname>Benefield</surname><given-names>C</given-names></name><etal/></person-group><article-title>Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro</article-title><source><italic>Journal of Cancer Research and Clinical Oncology</italic></source><year>1994</year><volume>120, supplement 1</volume><fpage>S3</fpage><lpage>S10</lpage><pub-id pub-id-type="pmid">7510710</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>RB</given-names></name><name><surname>Parker</surname><given-names>M</given-names></name><name><surname>Grizzle</surname><given-names>WE</given-names></name></person-group><article-title>The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines</article-title><source><italic>Journal of Cancer Research and Clinical Oncology</italic></source><year>1994</year><volume>120, supplement 1</volume><fpage>S11</fpage><lpage>S13</lpage><pub-id pub-id-type="pmid">8132694</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaii</surname><given-names>S</given-names></name><name><surname>Tomono</surname><given-names>Y</given-names></name><name><surname>Ogawa</surname><given-names>K</given-names></name><name><surname>Sugiura</surname><given-names>M</given-names></name><name><surname>Yano</surname><given-names>M</given-names></name><name><surname>Yoshizawa</surname><given-names>Y</given-names></name></person-group><article-title>The antiproliferative effect of coumarins on several cancer cell lines</article-title><source><italic>Anticancer Research</italic></source><year>2001</year><volume>21</volume><issue>2A</issue><fpage>917</fpage><lpage>923</lpage><pub-id pub-id-type="pmid">11396185</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Manolov</surname><given-names>I</given-names></name><name><surname>Nicolova</surname><given-names>I</given-names></name><name><surname>Konstantinov</surname><given-names>S</given-names></name><name><surname>Karaivanova</surname><given-names>M</given-names></name></person-group><article-title>New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity</article-title><source><italic>European Journal of Medicinal Chemistry</italic></source><year>2001</year><volume>36</volume><issue>4</issue><fpage>339</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">11461759</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Manolov</surname><given-names>I</given-names></name><name><surname>Konstantinov</surname><given-names>S</given-names></name><name><surname>Karaivanova</surname><given-names>M</given-names></name></person-group><article-title>Synthesis, physicochemical characterisation and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Warfarin and Coumachlor sodium salts</article-title><source><italic>European Journal of Medicinal Chemistry</italic></source><year>1999</year><volume>34</volume><issue>1</issue><fpage>63</fpage><lpage>68</lpage></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manolov</surname><given-names>I</given-names></name><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Konstantinov</surname><given-names>S</given-names></name><name><surname>Karaivanova</surname><given-names>M</given-names></name></person-group><article-title>Synthesis, physicochemical characterization and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Niffcoumar sodium salt</article-title><source><italic>European Journal of Medicinal Chemistry</italic></source><year>1999</year><volume>34</volume><issue>10</issue><fpage>853</fpage><lpage>858</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manolov</surname><given-names>I</given-names></name><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Netzeva</surname><given-names>T</given-names></name><name><surname>Konstantinov</surname><given-names>S</given-names></name><name><surname>Karaivanova</surname><given-names>M</given-names></name></person-group><article-title>Cytotoxic activity of cerium complexes with coumarin derivatives. Molecular modeling of the ligands</article-title><source><italic>Archiv der Pharmazie: Pharmaceutical and Medicinal Chemistry</italic></source><year>2000</year><volume>333</volume><issue>4</issue><fpage>93</fpage><lpage>98</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Manolov</surname><given-names>I</given-names></name><name><surname>Nicolova</surname><given-names>I</given-names></name><name><surname>Danchev</surname><given-names>ND</given-names></name></person-group><article-title>New metal complexes of 4-methyl-7-hydroxycoumarin sodium salt and their pharmacological activity</article-title><source><italic>Il Farmaco</italic></source><year>2001</year><volume>56</volume><issue>9</issue><fpage>707</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">11680816</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Manolov</surname><given-names>I</given-names></name><name><surname>Karaivanova</surname><given-names>M</given-names></name></person-group><article-title>Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives</article-title><source><italic>Archiv der Pharmazie: Pharmaceutical and Medicinal Chemistry</italic></source><year>2001</year><volume>334</volume><issue>5</issue><fpage>157</fpage><lpage>162</lpage></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Manolov</surname><given-names>I</given-names></name><name><surname>Momekov</surname><given-names>G</given-names></name></person-group><article-title>Cytotoxic activity of new neodymium (III) complexes of bis-coumarins</article-title><source><italic>European Journal of Medicinal Chemistry</italic></source><year>2004</year><volume>39</volume><issue>9</issue><fpage>765</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">15337289</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Trendafilova</surname><given-names>N</given-names></name><name><surname>Momekov</surname><given-names>G</given-names></name></person-group><article-title>Theoretical and spectroscopic evidence for coordination ability of 3,3&#x02032;-benzylidenedi-4-hydroxycoumarin. New neodymium (III) complex and its cytotoxic effect</article-title><source><italic>Journal of Inorganic Biochemistry</italic></source><year>2005</year><volume>99</volume><issue>2</issue><fpage>477</fpage><lpage>487</lpage><pub-id pub-id-type="pmid">15621280</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Momekov</surname><given-names>G</given-names></name><name><surname>Zaharieva</surname><given-names>M</given-names></name><name><surname>Karaivanova</surname><given-names>M</given-names></name></person-group><article-title>Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins</article-title><source><italic>European Journal of Medicinal Chemistry</italic></source><year>2005</year><volume>40</volume><issue>6</issue><fpage>542</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">15922838</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Trendafilova</surname><given-names>N</given-names></name><name><surname>Mihaylov</surname><given-names>T</given-names></name></person-group><article-title>Theoretical and spectroscopic studies of pyridyl substituted bis-coumarins and their new neodymium (III) complexes</article-title><source><italic>Chemical Physics</italic></source><year>2005</year><volume>314</volume><issue>1&#x02013;3</issue><fpage>73</fpage><lpage>84</lpage></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Manolov</surname><given-names>I</given-names></name><name><surname>Momekov</surname><given-names>G</given-names></name><name><surname>Tzanova</surname><given-names>T</given-names></name><name><surname>Konstantinov</surname><given-names>S</given-names></name><name><surname>Karaivanova</surname><given-names>M</given-names></name></person-group><article-title>Cytotoxic activity of new cerium (III) complexes of bis-coumarins</article-title><source><italic>European Journal of Medicinal Chemistry</italic></source><year>2005</year><volume>40</volume><issue>12</issue><fpage>1246</fpage><lpage>1254</lpage><pub-id pub-id-type="pmid">16143428</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drexler</surname><given-names>HG</given-names></name><name><surname>MacLeod</surname><given-names>RAF</given-names></name><name><surname>Uphoff</surname><given-names>CC</given-names></name></person-group><article-title>Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia</article-title><source><italic>Leukemia Research</italic></source><year>1999</year><volume>23</volume><issue>3</issue><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">10071072</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mihaylov</surname><given-names>Tz</given-names></name><name><surname>Trendafilova</surname><given-names>N</given-names></name><name><surname>Kostova</surname><given-names>I</given-names></name><name><surname>Georgieva</surname><given-names>I</given-names></name><name><surname>Bauer</surname><given-names>G</given-names></name></person-group><article-title>DFT modeling and spectroscopic study of metal-ligand bonding in La(III) complex of coumarin-3-carboxylic acid</article-title><source><italic>Chemical Physics</italic></source><year>2006</year><volume>327</volume><issue>2-3</issue><fpage>209</fpage><lpage>219</lpage></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgieva</surname><given-names>I</given-names></name><name><surname>Trendafilova</surname><given-names>N</given-names></name><name><surname>Kiefer</surname><given-names>W</given-names></name><name><surname>Rastogi</surname><given-names>VK</given-names></name><name><surname>Kostova</surname><given-names>I</given-names></name></person-group><article-title>Vibrational and theoretical study of coumarin-3-carboxylic acid
binding mode in Ce(III) and Nd(III) complexes</article-title><comment>to appear in <italic>Vibrational Spectroscopy</italic>.</comment></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>The structure of the ligand (HCCA, coumarin-3-carboxylic acid).</p></caption><graphic xlink:href="MBD2007-15925.001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Experimental FT-Raman spectra of coumarin-3-carboxylic acid (HCCA) and its <chem-struct>Sm(III), Gd(III), and Dy(III)</chem-struct> complexes in the range
1800&#x02013;200 cm<sup>&#x02212;1</sup>.</p></caption><graphic xlink:href="MBD2007-15925.002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Cytotoxic effect of <chem-struct>Sm(CCA)<sub>2</sub>(NO<sub>3</sub>) &#x000b7; H<sub>2</sub>O</chem-struct> on the chronic myeloid leukemia-derived K-562 cell line after 48-hour exposure, as assessed by the MTT-dye reduction
assay. Each data point represents the mean &#x000b1; SD (<italic>n</italic> &#x02265; 6).</p></caption><graphic xlink:href="MBD2007-15925.003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Cytotoxic effect of <chem-struct>Gd(CCA)<sub>2</sub>(NO<sub>3</sub>) &#x000b7; H<sub>2</sub>O</chem-struct> on the chronic myeloid leukemia-derived K-562 cell line after 48-hour exposure, as assessed by the MTT-dye reduction
assay. Each data point represents the mean &#x000b1; SD (<italic>n</italic> &#x02265; 6).</p></caption><graphic xlink:href="MBD2007-15925.004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p>Cytotoxic effect of <chem-struct>Dy(CCA)<sub>2</sub>(NO<sub>3</sub>) &#x000b7; H<sub>2</sub>O</chem-struct> on the chronic myeloid leukemia-derived K-562 cell line after 48-hour exposure, as assessed by the MTT-dye reduction
assay. Each data point represents the mean &#x000b1; SD (<italic>n</italic> &#x02265; 6).</p></caption><graphic xlink:href="MBD2007-15925.005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><p>Cytotoxic effect of <chem-struct>Sm(NO<sub>3</sub>)<sub>3</sub> &#x000b7; 6H<sub>2</sub>O</chem-struct> on the chronic myeloid leukemia-derived K-562 cell line after 48-hour exposure, as assessed by the MTT-dye reduction assay. Each data point represents the mean &#x000b1; SD (<italic>n</italic> &#x02265; 6).</p></caption><graphic xlink:href="MBD2007-15925.006"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><p>Cytotoxic effect of <chem-struct>Gd(NO<sub>3</sub>)<sub>3</sub> &#x000b7; 6H<sub>2</sub>O</chem-struct> on the chronic myeloid leukemia-derived K-562 cell line after 48-hour exposure, as assessed by the MTT-dye reduction assay. Each data point represents the mean &#x000b1; SD (<italic>n</italic> &#x02265; 6).</p></caption><graphic xlink:href="MBD2007-15925.007"/></fig><fig id="F8" position="float"><label>Figure 8</label><caption><p>Cytotoxic effect of <chem-struct>Dy(NO<sub>3</sub>)<sub>3</sub> &#x000b7; 5H<sub>2</sub>O</chem-struct> on the chronic myeloid leukemia-derived K-562 cell line after 48-hour exposure, as assessed by the MTT-dye reduction assay. Each data point represents the mean &#x000b1; SD (<italic>n</italic> &#x02265; 6).</p></caption><graphic xlink:href="MBD2007-15925.008"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Elemental analysis of <chem-struct>Ln(III)</chem-struct> complexes of
coumarin-3-carboxilic acid. <chem-struct>HCCA = C<sub>10</sub>H<sub>6</sub>O<sub>4</sub></chem-struct>; <chem-struct>CCA = C<sub>10</sub>H<sub>5</sub>O<sub>4</sub><sup>&#x02212;</sup></chem-struct>.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1">Compound</td><td align="center" colspan="5" rowspan="1">Calculated/found (%)</td></tr><tr><td colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="1" colspan="1">Formulae</td><td align="center" rowspan="1" colspan="1">
<chem-struct>C</chem-struct>
</td><td align="center" rowspan="1" colspan="1">
<chem-struct>H</chem-struct>
</td><td align="center" rowspan="1" colspan="1">
<chem-struct>N</chem-struct>
</td><td align="center" rowspan="1" colspan="1">
<chem-struct>H<sub>2</sub>O</chem-struct>
</td><td align="center" rowspan="1" colspan="1">
<chem-struct>Ln</chem-struct>
</td></tr><tr><td colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="2" colspan="1">
<chem-struct>Sm(CCA)<sub>2</sub>(NO<sub>3</sub>) &#x000b7; H<sub>2</sub>O</chem-struct>
</td><td align="center" rowspan="1" colspan="1">39,47/</td><td align="center" rowspan="1" colspan="1">1,97/</td><td align="center" rowspan="1" colspan="1">2,30/</td><td align="center" rowspan="1" colspan="1">2,96/</td><td align="center" rowspan="1" colspan="1">24,67/</td></tr><tr><td align="center" rowspan="1" colspan="1">39,09</td><td align="center" rowspan="1" colspan="1">2,02</td><td align="center" rowspan="1" colspan="1">2,77</td><td align="center" rowspan="1" colspan="1">2,73</td><td align="center" rowspan="1" colspan="1">24,25</td></tr><tr><td colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="2" colspan="1">
<chem-struct>Gd(CCA)<sub>2</sub>(NO<sub>3</sub>) &#x000b7; H<sub>2</sub>O</chem-struct>
</td><td align="center" rowspan="1" colspan="1">39,02/</td><td align="center" rowspan="1" colspan="1">1,95/</td><td align="center" rowspan="1" colspan="1">2,28/</td><td align="center" rowspan="1" colspan="1">2,92/</td><td align="center" rowspan="1" colspan="1">25,53/</td></tr><tr><td align="center" rowspan="1" colspan="1">39,38</td><td align="center" rowspan="1" colspan="1">2,28</td><td align="center" rowspan="1" colspan="1">2,49</td><td align="center" rowspan="1" colspan="1">2,69</td><td align="center" rowspan="1" colspan="1">25,22</td></tr><tr><td colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="2" colspan="1">
<chem-struct>Dy(CCA)<sub>2</sub>(NO<sub>3</sub>) &#x000b7; H<sub>2</sub>O</chem-struct>
</td><td align="center" rowspan="1" colspan="1">38,71/</td><td align="center" rowspan="1" colspan="1">1,94/</td><td align="center" rowspan="1" colspan="1">2,26/</td><td align="center" rowspan="1" colspan="1">2,90/</td><td align="center" rowspan="1" colspan="1">26,13/</td></tr><tr><td align="center" rowspan="1" colspan="1">38,90</td><td align="center" rowspan="1" colspan="1">1,86</td><td align="center" rowspan="1" colspan="1">2,05</td><td align="center" rowspan="1" colspan="1">2,58</td><td align="center" rowspan="1" colspan="1">25,84</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Experimental vibrational frequencies of <chem-struct>HCCA</chem-struct> and its <chem-struct>Ln(III)</chem-struct> complexes.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="center" colspan="2" rowspan="1">
<chem-struct>HCCA</chem-struct>
</td><td align="center" colspan="2" rowspan="1">
<chem-struct>Sm</chem-struct>-<chem-struct>HCCA</chem-struct>
</td><td align="center" colspan="2" rowspan="1">
<chem-struct>Gd</chem-struct>-<chem-struct>HCCA</chem-struct>
</td><td align="center" colspan="2" rowspan="1">
<chem-struct>Dy</chem-struct>-<chem-struct>HCCA</chem-struct>
</td><td align="center" rowspan="2" colspan="1">Assignments</td></tr><tr><td align="center" rowspan="1" colspan="1">
<chem-struct>IR</chem-struct>
</td><td align="center" rowspan="1" colspan="1">Raman</td><td align="center" rowspan="1" colspan="1">
<chem-struct>IR</chem-struct>
</td><td align="center" rowspan="1" colspan="1">Raman</td><td align="center" rowspan="1" colspan="1">
<chem-struct>IR</chem-struct>
</td><td align="center" rowspan="1" colspan="1">Raman</td><td align="center" rowspan="1" colspan="1">
<chem-struct>IR</chem-struct>
</td><td align="center" rowspan="1" colspan="1">Raman</td></tr><tr><td colspan="9" rowspan="1">
<hr/>
</td></tr><tr><td align="center" rowspan="1" colspan="1">3176 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(OH)<sub>coum</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">3057 w</td><td align="center" rowspan="1" colspan="1">3066 w</td><td align="center" rowspan="1" colspan="1">3050 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">3051 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">3054 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(CH)</chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">2956 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">2953 vw</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">2953 vw</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">2953 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(CH)</chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">2926 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">2924 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">2922 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">2924 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(CH)</chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">1746 vs</td><td align="center" rowspan="1" colspan="1">1729 m</td><td align="center" rowspan="1" colspan="1">1703 m</td><td align="center" rowspan="1" colspan="1">1692 m</td><td align="center" rowspan="1" colspan="1">1703 s</td><td align="center" rowspan="1" colspan="1">1692 m</td><td align="center" rowspan="1" colspan="1">1705 vs</td><td align="center" rowspan="1" colspan="1">1690 m</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(C=O)<sub>carboxylic</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">1685 s</td><td align="center" rowspan="1" colspan="1">1676 m</td><td align="center" rowspan="1" colspan="1">1672 vs</td><td align="center" rowspan="1" colspan="1">1660 m</td><td align="center" rowspan="1" colspan="1">1672 s</td><td align="center" rowspan="1" colspan="1">1659 m</td><td align="center" rowspan="1" colspan="1">1684 sh</td><td align="center" rowspan="1" colspan="1">1659 m</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(C=O)<sub>carbonylic</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1663 m</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1674 s</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" rowspan="1" colspan="1">1613 s</td><td align="center" rowspan="1" colspan="1">1608 vs</td><td align="center" rowspan="1" colspan="1">1613 vs</td><td align="center" rowspan="1" colspan="1">1600 vs</td><td align="center" rowspan="1" colspan="1">1613 vs</td><td align="center" rowspan="1" colspan="1">1600 vs</td><td align="center" rowspan="1" colspan="1">1615 vs</td><td align="center" rowspan="1" colspan="1">1600 vs</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(CC)</chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">1569 s</td><td align="center" rowspan="1" colspan="1">1559 m</td><td align="center" rowspan="1" colspan="1">1572 s</td><td align="center" rowspan="1" colspan="1">1561 s</td><td align="center" rowspan="1" colspan="1">1572 s</td><td align="center" rowspan="1" colspan="1">1561 s</td><td align="center" rowspan="1" colspan="1">1581 vs</td><td align="center" rowspan="1" colspan="1">1563 s</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(CC)</chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1553 s</td><td align="center" rowspan="1" colspan="1">1540 m</td><td align="center" rowspan="1" colspan="1">1556 s</td><td align="center" rowspan="1" colspan="1">1540 m</td><td align="center" rowspan="1" colspan="1">1556 s</td><td align="center" rowspan="1" colspan="1">1538 m</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" rowspan="1" colspan="1">1489 w</td><td align="center" rowspan="1" colspan="1">1483 w</td><td align="center" rowspan="1" colspan="1">1510 m</td><td align="center" rowspan="1" colspan="1">1445 m</td><td align="center" rowspan="1" colspan="1">1512 m</td><td align="center" rowspan="1" colspan="1">1448 m</td><td align="center" rowspan="1" colspan="1">1485 vw</td><td align="center" rowspan="1" colspan="1">1447 m</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(CC)</chem-struct> + <italic>&#x003b4;</italic>
<chem-struct>(CCH)<sub>ip</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">1453 w</td><td align="center" rowspan="1" colspan="1">1442 w</td><td align="center" rowspan="1" colspan="1">1456 m</td><td align="center" rowspan="1" colspan="1">1406 w</td><td align="center" rowspan="1" colspan="1">1458 m</td><td align="center" rowspan="1" colspan="1">1406 m</td><td align="center" rowspan="1" colspan="1">1458 m</td><td align="center" rowspan="1" colspan="1">1405 w</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(CC)</chem-struct> + <italic>&#x003b4;</italic>
<chem-struct>(CCH)<sub>ip</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1408 s</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1410 s</td><td align="center" rowspan="1" colspan="1">1380 br</td><td align="center" rowspan="1" colspan="1">1408 s</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" rowspan="1" colspan="1">1422 s</td><td align="center" rowspan="1" colspan="1">1413 vw</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003b4;</italic>
<chem-struct>(COH)<sub>ip</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">1374 m</td><td align="center" rowspan="1" colspan="1">1363 s</td><td align="center" rowspan="1" colspan="1">1355 w</td><td align="center" rowspan="1" colspan="1">1323 m</td><td align="center" rowspan="1" colspan="1">1356 w</td><td align="center" rowspan="1" colspan="1">1323 m</td><td align="center" rowspan="1" colspan="1">1385 vs</td><td align="center" rowspan="1" colspan="1">1320 m</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(CC)</chem-struct> + <italic>&#x003b4;</italic>
<chem-struct>(CCH)<sub>ip</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">1228 s</td><td align="center" rowspan="1" colspan="1">1216 s</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1204 s</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1207 s</td><td align="center" rowspan="1" colspan="1">1215 w</td><td align="center" rowspan="1" colspan="1">1204 s</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>(C&#x02212;O)<sub>lactone</sub>
</td></tr><tr><td align="center" rowspan="1" colspan="1">1208 s</td><td align="center" rowspan="1" colspan="1">1197 vs</td><td align="center" rowspan="1" colspan="1">1299 sh</td><td align="center" rowspan="1" colspan="1">1275 w</td><td align="center" rowspan="1" colspan="1">1287 sh</td><td align="center" rowspan="1" colspan="1">1278 w</td><td align="center" rowspan="1" colspan="1">1255 m</td><td align="center" rowspan="1" colspan="1">1278 w</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>(C&#x02212;O)<sub>carboxylic</sub>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1282 s</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1283 m</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1263 m</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1262 m</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1262 m</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(NO)<sup>as</sup></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1053 w</td><td align="center" rowspan="1" colspan="1">1040 m</td><td align="center" rowspan="1" colspan="1">1049 w</td><td align="center" rowspan="1" colspan="1">1040 m</td><td align="center" rowspan="1" colspan="1">1049 w</td><td align="center" rowspan="1" colspan="1">1043 m</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003b4;</italic>
<chem-struct>(ONO)</chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">989 m</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">976 w</td><td align="center" rowspan="1" colspan="1">984 w</td><td align="center" rowspan="1" colspan="1">971 vw</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">964 w</td><td align="center" rowspan="1" colspan="1">986 w</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003b4;</italic>
<chem-struct>(CCH)<sub>op</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">802 s</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003b4;</italic>
<chem-struct>(COH)<sub>op</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">786 w</td><td align="center" rowspan="1" colspan="1">777 w</td><td align="center" rowspan="1" colspan="1">791 vw</td><td align="center" rowspan="1" colspan="1">772 w</td><td align="center" rowspan="1" colspan="1">781 w</td><td align="center" rowspan="1" colspan="1">777 w</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003b4;</italic>
<chem-struct>(ONO)</chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">767 m</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">768 m</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">766 s</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003b4;</italic>
<chem-struct>(OCO)<sub>ip(cabox)</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">748 w</td><td align="center" rowspan="1" colspan="1">740 m</td><td align="center" rowspan="1" colspan="1">749 w</td><td align="center" rowspan="1" colspan="1">740 m</td><td align="center" rowspan="1" colspan="1">750 w</td><td align="center" rowspan="1" colspan="1">740 m</td><td align="center" rowspan="1" colspan="1">+<italic>&#x003bd;</italic>
<chem-struct>(Ln&#x02212;O)<sub>carboxylic</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">725 vw</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">725 vw</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">713 vw</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003b4;</italic>
<chem-struct>(ONO)</chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">459 w</td><td align="center" rowspan="1" colspan="1">468 w</td><td align="center" rowspan="1" colspan="1">457 w</td><td align="center" rowspan="1" colspan="1">475 w</td><td align="center" rowspan="1" colspan="1">457 w</td><td align="center" rowspan="1" colspan="1">469 w</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(Ln&#x02212;O)<sub>carbonylic</sub></chem-struct>
</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">449 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">449 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">449 w</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">No data</td><td align="center" rowspan="1" colspan="1">209 w</td><td align="center" rowspan="1" colspan="1">No data</td><td align="center" rowspan="1" colspan="1">206 w</td><td align="center" rowspan="1" colspan="1">No data</td><td align="center" rowspan="1" colspan="1">211 vw</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003bd;</italic>
<chem-struct>(Ln&#x02212;O<sub>NO3</sub>)</chem-struct>
</td></tr></tbody></table></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Relative potency of the investigated compounds in the
panel of human tumor cell line K-562, following 48-hour treatment
(MTT-dye reduction assay).</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="center" rowspan="1" colspan="1">Compound</td><td align="center" rowspan="1" colspan="1">
<chem-struct>IC<sub>50</sub></chem-struct> value<xref ref-type="table-fn" rid="TF1">
<sup>(a)</sup>
</xref>
</td></tr><tr><td colspan="2" rowspan="1">
<hr/>
</td></tr><tr><td align="center" rowspan="1" colspan="1">
<chem-struct>Sm(CCA)<sub>2</sub>(NO<sub>3</sub>) &#x000b7; H<sub>2</sub>O</chem-struct>
</td><td align="center" rowspan="1" colspan="1">108.39 &#x000b1; 6.9 <italic>&#x003bc;</italic>M</td></tr><tr><td align="center" rowspan="1" colspan="1">
<chem-struct>Gd(CCA)<sub>2</sub>(NO<sub>3</sub>) &#x000b7; H<sub>2</sub>O</chem-struct>
</td><td align="center" rowspan="1" colspan="1">164.52 &#x000b1; 11.23 <italic>&#x003bc;</italic>M</td></tr><tr><td align="center" rowspan="1" colspan="1">
<chem-struct>Dy(CCA)<sub>2</sub>(NO<sub>3</sub>) &#x000b7; H<sub>2</sub>O</chem-struct>
</td><td align="center" rowspan="1" colspan="1">&#x0003e;200 <italic>&#x003bc;</italic>M</td></tr><tr><td align="center" rowspan="1" colspan="1">
<chem-struct>Sm(NO<sub>3</sub>)<sub>3</sub> &#x000b7; 6H<sub>2</sub>O</chem-struct>
</td><td align="center" rowspan="1" colspan="1">&#x0003e;200 <italic>&#x003bc;</italic>M</td></tr><tr><td align="center" rowspan="1" colspan="1">
<chem-struct>Gd(NO<sub>3</sub>)<sub>3</sub> &#x000b7; 6H<sub>2</sub>O</chem-struct>
</td><td align="center" rowspan="1" colspan="1">41.35 &#x000b1; 5.9 <italic>&#x003bc;</italic>M</td></tr><tr><td align="center" rowspan="1" colspan="1">
<chem-struct>Dy(NO<sub>3</sub>)<sub>3</sub> &#x000b7; 5H<sub>2</sub>O</chem-struct>
</td><td align="center" rowspan="1" colspan="1">76.78 &#x000b1; 4.72 <italic>&#x003bc;</italic>M</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>
<sup>(a)</sup>Data represent the arithmetic mean &#x000b1; standard deviation of six independent experiments.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
